CTRI/2018/03/012303
Active, Not Recruiting
Phase 1
Clinical evaluation of the safety and efficacy of the investigational product containing herbal actives for hair growth and hair quality in subjects experiencing hair loss - NI
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dabur Research Foundation
- Status
- Active, Not Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Male and female subjectsâ?? in general good health.
- •2\.Subjects in the age group 18\-45 years (both the ages inclusive).
- •3\.Subjects willing to give a written informed consent and agree to come for a regular follow up visit.
- •4\.Subjects with hair fall\- above 20 hair fall in comb test (with bulb\+ without bulb)
- •5\.Subjects with follicular density above 100\-200
- •6\.Subjects complaining of hair fall
- •7\.Subjects complaining about hair thinning
- •8\.Subjects who have not participated in a similar investigation in the past three months.
- •9\.Healthy volunteers with no known allergy as established by medical history.
- •10\.Subjects who do not smoke or drink
Exclusion Criteria
- •1\.A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products.
- •2\.Subjects who have had hair transplant.
- •3\.Subjects who take pharmaceutical product which cause hirsutism (ex. phenytoin) and finesteride for androgenic alopecia
- •4\.Subjects who have undergone hair growth treatment within 3 months before screening into the study.
- •5\.Subjects having any active scalp diseasewhichmayinterfere in the studydermatologistâ??sjudgement.
- •6\.Subjects who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study.
- •7\.Subjects who have history of alcoholism and/ or psychiatric disorder including trichotillomania.
- •8\.Subjects consuming alcohol and smoking
- •9\.Subjects on oral medications which will compromise the study.
- •10\.Subjects who are pregnant or lactating or nursing as established with medical history.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Clinical evaluation of the efficacy and safety of Hochuekkito for fatigue in patients with myeloproliferative neoplasmsmyeloproliferative neoplasmsJPRN-UMIN000031519Department of Hematology, Juntendo University School of Medicine110
Recruiting
Early Phase 1
Clinical evaluation of the efficacy and safety of Huayu Tongbi Fomular on rheumatoid arthritisRheumatoid ArthritisITMCTR2024000092Guangdong Provincial Hospital of Chinese Medicine
Completed
Phase 3
Clinical evaluation of the safety and effectiveness of Excilor 2-in-1 Wart Treatment in the treatment of warts on the hands and feetISRCTN39469406Medical Brands66
Unknown
Phase 2
Clinical evaluation of the efficacy and safety of the guideline of oral ingestion of NaCl for children with ileostomyileostomyJPRN-UMIN000016711Division of Pediatric Surgery, Department of Surgery, Kobe University Graduate School of Medicine30
Completed
N/A
Clinical evaluation of the efficacy and safety of robot-assisted hysterectomy using da Vinci surgical system for benign gynecologic diseaseBenign gynecologic disease such as uterine myomas, adenomyosis, etc.JPRN-UMIN000040068Kitasato University Hospital5